Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

Clinical trial NCT01601093 · SUSPENDED

Trial details

NCT number: NCT01601093
Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Tract Infections Urinary Tract Infections

Start date: 2011-11-01
Primary completion: 2022-08-15
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.